Small node-negative breast cancers may retain aggressive characteristics

Adaptive TONIC trial of nivolumab combinations for breast cancer

Returning to work after cancer

Financial and ethical safety in cancer care

Phase Ib/II trial of combination PD-1 therapy against kidney cancer

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

PACIFIC trial of durvalumab for stage III NSCLC

Follow-up on the IFCT-0302 trial

PACIFIC trial of durvalumab for lung cancer

ESMO 2017: CDK4/6 inhibitors from a patient’s perspective

Editor's Choice for August 2017

Emerging targets for the treatment of lung cancer